Diploma PLC (LON:DPLM – Get Rating) has been assigned an average rating of “Moderate Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is GBX 2,940 ($35.42).
DPLM has been the topic of several analyst reports. Shore Capital reissued a “buy” rating on shares of Diploma in a report on Thursday, July 21st. Barclays reaffirmed an “overweight” rating and issued a GBX 3,290 ($39.64) price objective on shares of Diploma in a research note on Friday, July 22nd. Royal Bank of Canada raised Diploma to a “sector perform” rating and reduced their price objective for the company from GBX 2,600 ($31.33) to GBX 2,450 ($29.52) in a research note on Tuesday, May 17th. JPMorgan Chase & Co. reduced their price objective on Diploma from GBX 2,450 ($29.52) to GBX 2,100 ($25.30) and set an “underweight” rating on the stock in a research note on Wednesday, June 29th. Finally, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 3,360 ($40.48) price objective on shares of Diploma in a research note on Tuesday.
Diploma Stock Performance
DPLM opened at GBX 2,644 ($31.86) on Thursday. The firm has a market cap of £3.29 billion and a P/E ratio of 4,481.36. Diploma has a 52-week low of GBX 2,090 ($25.18) and a 52-week high of GBX 3,504 ($42.22). The company has a debt-to-equity ratio of 73.00, a quick ratio of 1.45 and a current ratio of 2.37. The business’s fifty day moving average is GBX 2,398.78 and its 200-day moving average is GBX 2,590.92.
Diploma Cuts Dividend
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, rest of Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies clinical diagnostics instrumentation and products, consumables, specialty surgical devices, and related consumables and services to public hospitals, private clinics, pathology laboratories, scientific research, and medical segments; surgical equipment for hospital operating rooms; and distributes laboratory diagnostics, specialty medical devices, devices, equipment, and patient monitoring technologies used in operating theatres, as well as medically supervised nutrition.
- Shopify Stock Rallies Despite Quarterly Loss
- Two Automation Stocks The Institutions Are Buying
- Can Owens-Corning Insulate Your Portfolio?
- Consumer Staple Kraft-Heinz Quietly Builds Momentum
- Steady, Stable Kimberly-Clark Yields 3.4%
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.